EMD Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial - 30th Jan 2023, 9:37am

annb0t

annb0t

Top 20
EMD Ann: First dosing commenced for pivotal EMD-RX5 Phase 3 trial
Price Sensitive: Y
Date: 30th Jan 2023, 9:37am

>>> Read announcement: Google: EMD Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
EMD Ann: Emyria's Clinic Achieves Key MDMA-AT Dosing Milestone - 9th Oct 2023, 9:15am
Replies
0
Views
60
annb0t
annb0t
annb0t
EMD Ann: Emyria Secures Local MDMA to Start PTSD Trial Dosing - 21st Sep 2023, 8:37am
Replies
0
Views
98
annb0t
annb0t
annb0t
EMD Ann: EMD-RX5 Dosing to Complete for Phase 1 Clinical Trial - 14th Apr 2022, 9:47am
Replies
0
Views
164
annb0t
annb0t
annb0t
EMD Ann: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial - 7th Apr 2022, 9:45am
Replies
0
Views
181
annb0t
annb0t
annb0t
EMD Ann: Results of General Meeting - 31st Oct 2023, 3:43pm
Replies
0
Views
79
annb0t
annb0t
Top Bottom